![Ben Shepherd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Ben Shepherd is the founder of Trestle Biotherapeutics, Inc. He held the title of Chief Executive Officer at the company, although he is no longer active in that role.
Cargos activos de Ben Shepherd
Empresas | Cargo | Inicio |
---|---|---|
Trestle Biotherapeutics, Inc.
![]() Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Trestle Biotherapeutics, Inc.
![]() Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | Commercial Services |
- Bolsa de valores
- Insiders
- Ben Shepherd